Allo-HSCT: Clinical Trials

2 trials of Allo-HSCT, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Recruiting 2

Follow Allo-HSCT: new trials by email Literature Review of Allo-HSCT trials Research Report on Allo-HSCT

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases
CD7 CAR-T cells injection, Allo-HSCT - Bone Marrow Failure Syndrome
Early Phase 1RecruitingZhejiang University202025-01-312025-01-22
Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the Treatment of SIOD
CD7 CAR-T cells injection, Allo-HSCT, Kidney Transplantation - Schimke Immuno-osseous Dysplasia
Early Phase 1RecruitingZhejiang University202025-01-302025-01-20

Conditions studied

Bone Marrow Failure Disorders (1)  ·  Schimke immunoosseous dysplasia (1)

Sponsors

Zhejiang University (2)

Countries

China (2)

Top investigators

He Huang, MD (2)